Treatment of autoimmune neutropenia with recombinant human granulocyte colony-stimulating factor

Assessment of response to therapy in multiple myeloma by multiparameter flow cytometry. Usefulness of an eight-color single tube with monoclonal antibodies in dried formulation.

La Clinica terapeutica·2019

Multiparameter immunophenotyping by flow cytometry as a diagnostic tool in multiple myeloma and monoclonal gammopathy of undetermined significance.

La Clinica terapeutica·2012

Diagnosis and classification of B-cell non-Hodgkin lymphomas. The role of multiparameter flow cytometry.

La Clinica terapeutica·2012

Combination of morphology, flow cytometry and PCR assay to detect bone marrow infiltration in B-cell non-Hodgkin's lymphomas.

La Clinica terapeutica·2010

Association of B-chronic lymphocytic leukemia and acute myeloid leukemia.

Journal of experimental & clinical cancer research : CR·2007

Recombinant human granulocyte colony-stimulating factor administration in a case of neutropenia due to increased neutrophil sequestration.

La Clinica terapeutica·2007

Outcomes of down syndrome-related myeloid leukemia in Turkiye: a multicenter retrospective observational cohort study by the Turkish Pediatric Hematology Association.

Annals of hematology·2026

Early deep response to cilta-cel as 2nd CAR T-Cell therapy after CELMoD-based bridging for advanced multiple myeloma.

Annals of hematology·2026

Chidamide plus venetoclax as effective and safe maintenance therapy in high-risk acute myeloid leukemia and myelodysplastic syndrome post-transplantation.

Annals of hematology·2026

Optimizing venetoclax duration with hypomethylating agents for newly diagnosed acute myeloid leukemia: impact on response and survival.

Annals of hematology·2026

Defining and managing high-risk acute myeloid leukemia (AML) in 2026.

Annals of hematology·2026

Durable CNS remission with elranatamab and intrathecal therapy in relapsed/refractory multiple myeloma.

Annals of hematology·2026

Targeting METTL3/m6A/SOCS3 axis reprograms tumor-associated macrophage polarization to potentiate the efficacy of anti-PD-1 therapy in multiple myeloma.

Cellular and molecular life sciences : CMLS·2026

Distinct clinical and immunologic patterns of interferon-γ release assays: implications for indeterminate results and sequential testing strategies.

Microbiology spectrum·2026

Recalcitrant Infectious Keratitis in DOCK8 Immunodeficiency Syndrome.

Journal of pediatric ophthalmology and strabismus·2026

Early but not serial ustekinumab concentration measurements are associated with clinical outcomes in Crohn's disease and ulcerative colitis: the Stockholm Ustekinumab study (STOCUSTE).

European journal of gastroenterology & hepatology·2026

Cost comparison of intravenous immunoglobulin and subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyneuropathy.

Journal of medical economics·2026

Head-to-head comparison of [18F]AlF-NOTA-JR11 PET/MR and [68Ga]Ga-DOTA-TATE PET/CT in patients with neuroendocrine tumors.

European journal of nuclear medicine and molecular imaging·2026

Related Experiment Videos

Treatment of autoimmune neutropenia with recombinant human granulocyte colony-stimulating factor

Related Concept Videos

Assessment of response to therapy in multiple myeloma by multiparameter flow cytometry. Usefulness of an eight-color single tube with monoclonal antibodies in dried formulation.

Multiparameter immunophenotyping by flow cytometry as a diagnostic tool in multiple myeloma and monoclonal gammopathy of undetermined significance.

Diagnosis and classification of B-cell non-Hodgkin lymphomas. The role of multiparameter flow cytometry.

Combination of morphology, flow cytometry and PCR assay to detect bone marrow infiltration in B-cell non-Hodgkin's lymphomas.

Association of B-chronic lymphocytic leukemia and acute myeloid leukemia.

Recombinant human granulocyte colony-stimulating factor administration in a case of neutropenia due to increased neutrophil sequestration.

Outcomes of down syndrome-related myeloid leukemia in Turkiye: a multicenter retrospective observational cohort study by the Turkish Pediatric Hematology Association.

Early deep response to cilta-cel as 2nd CAR T-Cell therapy after CELMoD-based bridging for advanced multiple myeloma.

Chidamide plus venetoclax as effective and safe maintenance therapy in high-risk acute myeloid leukemia and myelodysplastic syndrome post-transplantation.

Optimizing venetoclax duration with hypomethylating agents for newly diagnosed acute myeloid leukemia: impact on response and survival.

Defining and managing high-risk acute myeloid leukemia (AML) in 2026.

Durable CNS remission with elranatamab and intrathecal therapy in relapsed/refractory multiple myeloma.

Targeting METTL3/m6A/SOCS3 axis reprograms tumor-associated macrophage polarization to potentiate the efficacy of anti-PD-1 therapy in multiple myeloma.

Distinct clinical and immunologic patterns of interferon-γ release assays: implications for indeterminate results and sequential testing strategies.

Recalcitrant Infectious Keratitis in DOCK8 Immunodeficiency Syndrome.

Early but not serial ustekinumab concentration measurements are associated with clinical outcomes in Crohn's disease and ulcerative colitis: the Stockholm Ustekinumab study (STOCUSTE).

Cost comparison of intravenous immunoglobulin and subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyneuropathy.

Head-to-head comparison of [18F]AlF-NOTA-JR11 PET/MR and [68Ga]Ga-DOTA-TATE PET/CT in patients with neuroendocrine tumors.

Related Experiment Videos

Treatment of autoimmune neutropenia with recombinant human granulocyte colony-stimulating factor

Related Concept Videos

Related Articles